Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$887M |
| 2 |
Amazon
AMZN
|
+$857M |
| 3 |
Apple
AAPL
|
+$844M |
| 4 |
Microsoft
MSFT
|
+$802M |
| 5 |
Tesla
TSLA
|
+$606M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$760M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$515M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$258M |
| 4 |
Oracle
ORCL
|
+$126M |
| 5 |
PFPT
Proofpoint, Inc.
PFPT
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.53% |
| 2 | Financials | 13.97% |
| 3 | Healthcare | 13.42% |
| 4 | Consumer Discretionary | 11.85% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
CBIZ
CBZ
$2.96B
| $28M | ﹤0.01% |
864,623
-9,678
| -1% | -$315K |
|
1727
ICF International
ICFI
$1.58B
| $27.9M | ﹤0.01% |
312,729
-1,905
| -0.6% | -$173K |
|
1728
Lindsay Corp
LNN
$1.16B
| $27.9M | ﹤0.01% |
183,787
+5,135
| +3% | +$829K |
|
|
BWIN
1729
Baldwin Insurance Group
BWIN
$2.96B
| $27.9M | ﹤0.01% |
838,009
+34,234
| +4% | +$1.07M |
|
1730
Regenxbio
RGNX
$704M
| $27.9M | ﹤0.01% |
665,419
+2,711
| +0.4% | +$97.5K |
|
1731
LendingTree
TREE
$446M
| $27.9M | ﹤0.01% |
199,267
+1,626
| +0.8% | +$285K |
|
|
INFN
1732
DELISTED
Infinera Corporation Common Stock
INFN
| $27.8M | ﹤0.01% |
3,346,780
+42,572
| +1% | +$386K |
|
1733
American Well
AMWL
$221M
| $27.8M | ﹤0.01% |
152,738
+51,249
| +50% | +$11.1M |
|
1734
Telus
TU
$15.1B
| $27.8M | ﹤0.01% |
1,269,142
+150,760
| +13% | +$3.4M |
|
1735
Capitol Federal Financial
CFFN
$1.09B
| $27.7M | ﹤0.01% |
2,410,000
+34,808
| +1% | +$393K |
|
|
NXRT
1736
NexPoint Residential Trust
NXRT
$640M
| $27.7M | ﹤0.01% |
447,353
+2,534
| +0.6% | +$154K |
|
1737
Unisys
UIS
$206M
| $27.7M | ﹤0.01% |
1,100,673
+20,049
| +2% | +$474K |
|
|
FOE
1738
DELISTED
Ferro Corporation
FOE
| $27.6M | ﹤0.01% |
1,355,892
+26,915
| +2% | +$558K |
|
|
VRE
1739
DELISTED
Veris Residential
VRE
| $27.4M | ﹤0.01% |
1,602,491
-85,155
| -5% | -$1.48M |
|
1740
Applovin
APP
$105B
| $27.4M | ﹤0.01% |
378,659
+5,290
| +1% | +$360K |
|
1741
Virtu Financial
VIRT
$5.07B
| $27.3M | ﹤0.01% |
1,118,553
+35,203
| +3% | +$894K |
|
1742
Arcus Biosciences
RCUS
$3.67B
| $27.3M | ﹤0.01% |
783,176
+11,622
| +2% | +$362K |
|
1743
Butterfly Network
BFLY
$2.46B
| $27.2M | ﹤0.01% |
2,605,819
+1,257,160
| +93% | +$14.5M |
|
1744
HNI Corp
HNI
$3.58B
| $27.2M | ﹤0.01% |
740,639
+3,504
| +0.5% | +$136K |
|
1745
Coeur Mining
CDE
$18.8B
| $27.2M | ﹤0.01% |
4,405,407
+237,918
| +6% | +$1.69M |
|
1746
Green Plains
GPRE
$1.09B
| $27.1M | ﹤0.01% |
831,071
+86,046
| +12% | +$2.95M |
|
1747
Methode Electronics
MEI
$603M
| $27.1M | ﹤0.01% |
645,250
-34,897
| -5% | -$1.6M |
|
|
GBT
1748
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $27.1M | ﹤0.01% |
1,062,605
-40,358
| -4% | -$1.19M |
|
1749
Dave & Buster's
PLAY
$374M
| $26.9M | ﹤0.01% |
701,950
-78,955
| -10% | -$2.86M |
|
1750
St. Joe Company
JOE
$3.91B
| $26.9M | ﹤0.01% |
638,291
+9,066
| +1% | +$399K |
|
Similar funds
Geode Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Geode Capital Management held 4,944 positions worth $743B, up 2.3% from $726B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q3 2021 filing shows 223 new, 2,961 increased, 1,210 reduced and 86 closed positions. Its largest new stake was Lucid Motors: 565,353 shares worth $143M. The largest sale was Alexion Pharmaceuticals, an estimated $760M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2021 buy was Lucid Motors: 565,353 shares worth $143M.
- Geode Capital Management added most to Moderna in Q3 2021, an estimated $887M increase.
- Geode Capital Management's biggest Q3 2021 reduction was Oracle, cutting an estimated $126M.
- Geode Capital Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $760M.
- Geode Capital Management's ten largest holdings make up 23% of its $743B portfolio in Q3 2021.
- Geode Capital Management opened 223 new positions and closed 86 in Q3 2021.
- Geode Capital Management's portfolio value rose 2.3% quarter-over-quarter to $743B.
Based on Geode Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.